USSTOCK.TODAY
Regular Market
Log in Sign up

Protalix BioTherapeutics Inc. Reports $4 million in Third Quarter Profit

Associated Press · ·by G4L

PLX
PLX Protalix BioTherapeutics Inc
$2.57 +1.18%
View chart & analysis →
  1. 1Protalix BioTherapeutics Inc. reported a profit of $4 million in the third quarter.
  2. 2Protalix BioTherapeutics Inc. recorded $21.9 million in revenue for the third quarter.
  3. 3The annual revenue guidance for Protalix BioTherapeutics Inc. is between $78 million and $83 million.

So what's the key point?

Protalix BioTherapeutics Inc. earned a profit of $4 million in the third quarter. Revenue for this year is expected to be between $78 million and $83 million.

Source Associated Press · View original ↗

Related 3-line summaries

TransDigm Group Exceeds Market Expectations for Fourth Quarter Profit and Revenue Associated Press · 1h agoKemper Corp. reports $52.4 million in third-quarter net income Associated Press · 1h agoOraSure Technologies reports $13.1 million loss in Q3 Associated Press · 1h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news